Renal-replacement timing has no effect in kidney injury, sepsis

October 11, 2018

(HealthDay)—For patients with early-stage septic shock and severe acute kidney injury, 90-day mortality does not differ for patients randomly assigned to an early strategy for initiation of renal-replacement therapy versus a delayed strategy, according to a study published in the Oct. 11 issue of the New England Journal of Medicine.

Saber D. Barbar, M.D., Ph.D., from the Centre Hospitalier Universitaire de Nîmes in France, and colleagues conducted a trial involving patients with early-stage septic shock who had severe at the failure stage of the risk, injury, failure, loss, and end-stage kidney disease classification system. Patients were randomly assigned to receive renal-replacement therapy within 12 hours after documentation of failure-stage acute kidney injury (early ) or after a 48-hour delay if renal recovery had not occurred (delayed strategy); follow-up data at 90 days were available for 477 patients.

After the second planned interim analysis, the trial was stopped early for futility. The researchers found that 58 percent of patients in the early-strategy group and 54 percent in the delayed-strategy group had died (P = 0.38). Thirty-eight percent of patients in the delayed-strategy group did not receive renal-replacement therapy. Seventeen percent of in the delayed-strategy group met the criteria for emergency renal-replacement therapy.

"This trial showed no significant difference in mortality between a strategy of early initiation of renal-replacement and a strategy of delayed initiation," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Explore further: ATS: No benefit for early renal-replacement therapy

More information: Abstract/Full Text (subscription or payment may be required)

Related Stories

ATS: No benefit for early renal-replacement therapy

May 16, 2016
(HealthDay)—For patients with severe acute kidney injury, mortality does not differ with either an early or delayed strategy for renal-replacement therapy initiation, according to a study published online May 15 in the ...

Early renal replacement therapy ups survival in severe AKI

May 24, 2016
(HealthDay)—For patients with severe acute kidney injury (AKI), early initiation of renal replacement therapy (RRT) is associated with reduced mortality at 90 days, according to a study published online May 22 in the Journal ...

Acute critical illness increases risk of kidney complications and death

September 10, 2018
Acute critical illness in people without previous renal disease puts them at risk of kidney complications as well as death, according to a study in published in CMAJ (Canadian Medical Association Journal).

Should patients with cardiogenic shock receive culprit lesion only PCI or multivessel PCI?

October 31, 2017
Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found that an initial strategy of culprit lesion only percutaneous coronary intervention (PCI) reduces the composite of 30-day mortality and/or severe ...

ASN: Severe acute kidney injury ups risk of 28-day mortality

November 21, 2016
(HealthDay)—Acute kidney injury is associated with increased risk of 28-day mortality among critically ill children and young adults, according to a study published online Nov. 18 in the New England Journal of Medicine. ...

Initiation of renal replacement therapy impacts HRQoL

March 17, 2017
(HealthDay)—The initiation of renal replacement therapy (RRT) impacts health-related quality of life (HRQL) among patients with end-stage kidney disease, according to a study published online Feb. 27 in the Journal of Renal ...

Recommended for you

PET scans to optimize tuberculosis meningitis treatments and personalize care, study finds

December 6, 2018
Although relatively rare in the United States, and accounting for fewer than 5 percent of tuberculosis cases worldwide, TB of the brain—or tuberculosis meningitis (TBM)—is often deadly, always hard to treat, and a particular ...

Silicosis is on the rise, but is there a therapeutic target?

December 6, 2018
Researchers from the CNRS, the University of Orléans, and the company Artimmune, in collaboration with Turkish clinicians from Atatürk University, have identified a key mechanism of lung inflammation induced by silica exposure, ...

Infectivity of different HIV-1 strains may depend on which cell receptors they target

December 6, 2018
Distinct HIV-1 strains may differ in the nature of the CCR5 molecules to which they bind, affecting which cells they can infect and their ability to enter cells, according to a study published December 6 in the open-access ...

Protecting cell powerhouse paves way to better treatment of acute kidney injury

December 6, 2018
For the first time, scientists have described the body's natural mechanism for temporarily protecting the powerhouses of kidney cells when injury or disease means they aren't getting enough blood or oxygen.

New study uncovers why Rift Valley fever is catastrophic to developing fetuses

December 5, 2018
Like Zika, infection with Rift Valley fever virus can go unnoticed during pregnancy, all the while doing irreparable—often lethal—harm to the fetus. The results of a new study, led by researchers at the University of ...

Study highlights potential role of bioaerosol sampling to address airborne biological threats

December 5, 2018
As a leading global city with a high population density, Singapore is vulnerable to the introduction of biological threats. Initiating an early emergency response to such threats calls for the rapid identification of the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.